Investigational Drug Information for Tricaprilin
What is the drug development status for Tricaprilin?
Tricaprilin is an investigational drug.
There have been 14 clinical trials for Tricaprilin.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 30th 2022.
The most common disease conditions in clinical trials are Alzheimer Disease, Spasm, and Migraine Disorders. The leading clinical trial sponsors are Cerecin, Accera, Inc., and [disabled in preview].
There are zero US patents protecting this investigational drug and zero international patents.
Summary for Tricaprilin
| US Patents | 1,299 |
| International Patents | 6,851 |
| US Patent Applications | 3,160 |
| WIPO Patent Applications | 1,785 |
| Japanese Patent Applications | 1,638 |
| Clinical Trial Progress | Phase 2 (2022-06-30) |
| Vendors | 68 |
Recent Clinical Trials for Tricaprilin
| Title | Sponsor | Phase |
|---|---|---|
| Tricaprilin Phase 3 AD Study | Cerecin | Phase 3 |
| AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions | Cerecin | Phase 1 |
| A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects | Cerecin | Phase 1 |
Clinical Trial Summary for Tricaprilin
Top disease conditions for Tricaprilin
Top clinical trial sponsors for Tricaprilin
US Patents for Tricaprilin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tricaprilin | ⤷ Start Trial | Targeted poorly water-soluble drug delivery system, method of preparing the same, and pharmaceutical composition including the same | Samsung Life Public Welfare Foundation | ⤷ Start Trial |
| Tricaprilin | ⤷ Start Trial | Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse | Acura Pharmaceuticals, Inc. (Palatine, IL) | ⤷ Start Trial |
| Tricaprilin | ⤷ Start Trial | Stapled helical peptides and methods of synthesis | University of Hong Kong HKU | ⤷ Start Trial |
| Tricaprilin | ⤷ Start Trial | Oxidative hair dye composition | Hoyu Co Ltd | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tricaprilin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tricaprilin | European Patent Office | EP2896401 | 2032-09-12 | ⤷ Start Trial |
| Tricaprilin | South Korea | KR101493930 | 2032-09-12 | ⤷ Start Trial |
| Tricaprilin | South Korea | KR20140036338 | 2032-09-12 | ⤷ Start Trial |
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2014042450 | 2032-09-12 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
